An Innovative antibody-based Plug-and-Play strategy for SARS-CoV-2
J. Tushir-Singh, G. N. Shivange, D. Gogoi
This paper describes an antibody-based plug-and-play strategy that blocks SARS-CoV-2 spike protein proteolytic activation, using ACE2-overexpressing cells as a proof of concept.
bioRxiv · Mar 11, 2021 · PreprintBiochemistry